The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.

Source:http://linkedlifedata.com/resource/pubmed/id/18562401

Download in:

View as

General Info

PMID
18562401